[Available Resources for the Treatment of Breast Cancer in Mexico]

Overview

Journal Salud Publica Mex

Specialty Health Services

Date 2009 Dec 8

PMID 19967282

Citations 22

Authors

Alejandro Mohar

Enrique Bargallo

Ma Teresa Ramirez

Fernando Lara

Arturo Beltran-Ortega

Affiliations

Soon will be listed here.

Abstract

Objective: Describe the resources for the treatment of breast cancer in Mexico.

Methods: Information was obtained from 23 Centros Estatales de Cáncer (State Cancer Centers, CEC), two federal hospitals and Cancerología. This study was performed in Mexico City in August/September of 2008.

Results: These 23 centers provide medical care for breast cancer including surgery, chemotherapy and radiotherapy; all of them validated by the Seguro Popular. The costs were defined according to clinical stage and ranged from $27,500.00 pesos for clinical stage 0 to $480,00.00 in the advanced stage. A total of 2 689 women with breast cancer have been treated; only 1% was reported with in situ carcinoma.

Conclusions: An adequate medical infrastructure is in place to treat breast cancer in Mexico. The costs are high due to late diagnosis of the disease. Early detection of breast cancer is a high priority for optimal control of this disease in Mexico.

Citing Articles

Net costs of breast cancer in Colombia: a cost-of-illness study based on administrative claims databases.

Torres G, Alarcon B, Reyes-Sanchez J, Castano-Gamboa N, Buitrago G Cost Eff Resour Alloc. 2024; 22(1):54.

PMID: 38956674 PMC: 11218325. DOI: 10.1186/s12962-024-00562-z.

[Availability of mammographs in Mexico: Is it possible to expand coverage].

Sollozo-Dupont I, Galvan-Espinoza H, Villasenor Y Rev Med Inst Mex Seguro Soc. 2023; 61(6):736-746.

PMID: 37995285 PMC: 10715020. DOI: 10.5281/zenodo.10064296.

Non-timely referral of women aged 40 to 69 to preventive medicine for breast cancer detection and its association with the BI-RADS classification.

Gutierrez G, Garcia A, Benavente E, Mejia F, Gomez R, Villalon F Prev Med Rep. 2023; 35:102369.

PMID: 37654516 PMC: 10465932. DOI: 10.1016/j.pmedr.2023.102369.

Development and Pilot Implementation of the Genomic Risk Assessment for Cancer Implementation and Sustainment (GRACIAS) Intervention in Mexico.

Blazer K, Chavarri-Guerra Y, Garza C, Nehoray B, Mohar A, Daneri-Navarro A JCO Glob Oncol. 2021; 7:992-1002.

PMID: 34181458 PMC: 8457783. DOI: 10.1200/GO.20.00587.

Novel Mathematical Model of Breast Cancer Diagnostics Using an Associative Pattern Classification.

Santiago-Montero R, Sossa H, Gutierrez-Hernandez D, Zamudio V, Hernandez-Bautista I, Valadez-Godinez S Diagnostics (Basel). 2020; 10(3).

PMID: 32121569 PMC: 7151177. DOI: 10.3390/diagnostics10030136.